Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Tumor Angiogenesis: Therapeutic Implications

1971 • 9,898 citations

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

1999 • 2,565 citations

Clinical Applications of Research on Angiogenesis

1995 • 2,300 citations

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

2001 • 902 citations

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy

2000 • 868 citations

Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

2000 • 662 citations

Bone marrow angiogenesis and progression in multiple myeloma

1994 • 656 citations

Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma

1999 • 590 citations

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma

2000 • 547 citations

Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.

1999 • 543 citations

Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of Cancers

1994 • 478 citations

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

1995 • 450 citations

Smoldering Multiple Myeloma

1980 • 446 citations

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

2001 • 420 citations

“Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-Up

1993 • 343 citations

Prognostic value of bone marrow angiogenesis in multiple myeloma.

2000 • 321 citations

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]

1993 • 321 citations

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma

1999 • 252 citations

Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.

1997 • 225 citations

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.

2002 • 185 citations

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

1999 • 156 citations

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

2001 • 156 citations

Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma

2000 • 151 citations

Tumoral vascularity as a prognostic factor in cancer.

1996 • 146 citations

Expression of VEGF and its receptors by myeloma cells

2003 • 146 citations

A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma

2000 • 124 citations

Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

2001 • 112 citations

Angiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies

1995 • 106 citations

Bone marrow angiogenesis in patients with active multiple myeloma

2001 • 85 citations

Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies.

1988 • 77 citations

High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.

2001 • 70 citations

Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review.

1997 • 54 citations

Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy

2001 • 48 citations

Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma

2001 • 43 citations

A Review of Angiogenesis and Anti-Angiogenic Therapy in Hematologic Malignancies

2002 • 42 citations

Current status of thalidomide in the treatment of cancer.

2001 • 33 citations

Deleted Work

1955 • 0 citations